Cash & equivalents increased 179.7%
Cash & equivalents changed +179.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +179.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +176.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +168.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +234.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +83.9% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Current ratio changed +166.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed +547.6% from the comparable as-filed period.
Operating margin changed +376029 basis points from the comparable as-filed period.
Stock-based compensation changed -99.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross margin changed +3002 basis points from the comparable as-filed period.
Research & development changed -29.3% from the comparable as-filed period.
Cost of revenue changed +305.8% from the comparable as-filed period.
Working capital / assets changed +1746 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating cash flow changed -5.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
SBC / revenue changed -53439 basis points from the comparable as-filed period.
Operating income changed +3.4% from the comparable as-filed period.
Gross profit changed +1539.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Operating cash-flow margin changed +360320 basis points from the comparable as-filed period.
R&D / revenue changed -128659 basis points from the comparable as-filed period.
Current liabilities changed +3.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.